primary immune deficiencies
Showing 9976 - 10000 of >10,000
Chronic Daily Headache, Post-Traumatic Headache Trial in Montreal (Sphenopalatine ganglion block with 0.5% bupivacaine,
Not yet recruiting
- Chronic Daily Headache
- Post-Traumatic Headache
- Sphenopalatine ganglion block with 0.5% bupivacaine
- Sphenopalatine ganglion block with saline
-
Montreal, Quebec, CanadaMcGill University Health Centre (MUHC) - Montreal Children's Hos
Jan 14, 2022
Postpartum Depression Trial (HS-10353 Capsules 30 mg, Oral, QN for 14 days, HS-10353 Capsules 50 mg, Oral, QN for 14 days,
Not yet recruiting
- Postpartum Depression
- HS-10353 Capsules 30 mg, Oral, QN for 14 days
- +3 more
- (no location specified)
Jul 2, 2023
Laparoscopic Gynecological Surgery Trial in Seoul (procedure, drug, device)
Not yet recruiting
- Laparoscopic Gynecological Surgery
- EEG-and-ANI-guided anesthesia
- +3 more
-
Seoul, Korea, Republic ofGangnam Severance Hospital
Jun 29, 2023
Patient's With Rheumatoid Arthritis Trial in Sohag (Ultrasound)
Not yet recruiting
- Patient's With Rheumatoid Arthritis
- Ultrasound
-
Sohag, EgyptSohag University Hospital
Dec 14, 2021
Chronic Renal Failure, Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis
Recruiting
- Chronic Renal Failure
- Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis
- Dapagliflozin 10mg Tab
- +5 more
-
Marseille, France
- +1 more
May 23, 2023
Orphanin FQ in Patients With Chronic Ischemic Heart Failure
Not yet recruiting
- Heart Failure
- Enzyme linked immunosorbent assay
- (no location specified)
Oct 25, 2021
Loss of Chromosome 17p, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston (drug,
Completed
- Loss of Chromosome 17p
- +5 more
- Ibrutinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 4, 2022
Psoriasis Vulgaris Trial in Irvine (Belumosudil)
Completed
- Psoriasis Vulgaris
-
Irvine, CaliforniaUC Irvine Health, Dept of Dermatology
Mar 15, 2022
Glomerular Disease, Proteinuria Trial in Australia, Georgia, United States (ANG-3070, Placebo)
Recruiting
- Glomerular Disease
- Proteinuria
- ANG-3070
- Placebo
-
Birmingham, Alabama
- +29 more
Mar 22, 2022
Nucleophosmin 1-mutated Acute Myeloid Leukemia Trial in Worldwide (Entospletinib, Placebo, Cytarabine)
Recruiting
- Nucleophosmin 1-mutated Acute Myeloid Leukemia
- Entospletinib
- +3 more
-
Duarte, California
- +60 more
Jul 20, 2022
Renal Transplant Trial in Chapel Hill (Tacrolimus)
Completed
- Renal Transplant
-
Chapel Hill, North CarolinaUniveristy of North Carolina
Jul 18, 2022
Immunoglobulin DeficiencyTreatable Cause of Fatigue in Multiple
Recruiting
- Hypogammaglobulinemia
- +2 more
- Laboratory test
-
Bern, BE, SwitzerlandUniversity Hospital of Bern Inselspital
Sep 26, 2022
Primary Sjögren Syndrome Patients
Active, not recruiting
- Sjogren's Syndrome
- Parallel Assignment
-
São Paulo, Sao Paulo, Brazil
- +1 more
Nov 7, 2022
Bullous Pemphigoid Trial in Nice, Marseille, Montpellier (Avdoralimab (IPH5401), Control)
Recruiting
- Bullous Pemphigoid
- Avdoralimab (IPH5401)
- Control
-
Nice, Alpes-Maritimes, France
- +3 more
Feb 18, 2022
Eating Behavior Trial in University Park (Simultaneous Variety, Single-Food, Small Portion)
Active, not recruiting
- Eating Behavior
- Simultaneous Variety
- +3 more
-
University Park, PennsylvaniaLaboratory for the Study of Human Ingestive Behavior, The Pennsy
Jul 28, 2022
Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)
Not yet recruiting
- Recurrent Metastatic Melanoma
- +3 more
-
Boston, Massachusetts
- +1 more
Jul 29, 2022
NAFLD, Overweight and Obesity, Metabolic Syndrome Trial (Dietary composition of macronutrients and calories)
Not yet recruiting
- NAFLD
- +3 more
- Dietary composition of macronutrients and calories
- (no location specified)
Dec 1, 2022
Disc Disorder Trial in Izmir (i-PRF, Arthrocentesis)
Completed
- Disc Disorder
- i-PRF
- Arthrocentesis
-
İzmir, Bornova, TurkeyEge University Faculty of Dentistry
Dec 6, 2022
Prognostic Factors of Gullian Barrie Syndrome Outcome
Completed
- Guillain-Barre Syndrome
- plasmapheresis
-
Assuit, Assiut, EgyptAssiut university
Dec 7, 2022
Pressure-Volume Loop During High-Risk PCI
Recruiting
- Coronary Artery Disease
- High-risk percutaneous coronary intervention
-
Detroit, MichiganHenry Ford Hospital
Dec 6, 2022
Multiple Sclerosis Trial in Sao Paulo (Iyengar Yoga, Yoga app)
Active, not recruiting
- Multiple Sclerosis
- Iyengar Yoga
- Yoga app
-
Sao Paulo, BrazilHospital Israelita Albert Einstein
Jan 10, 2022
Metastatic Papillary Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial (Atezolizumab, Cabozantinib S-malate)
Recruiting
- Metastatic Papillary Renal Cell Carcinoma
- Stage IV Renal Cell Cancer AJCC v8
- Atezolizumab
- +4 more
-
Sacramento, California
- +38 more
Jan 17, 2023
Mesenchymal Stem Cell, COVID-19 Pneumonia Trial in Shanghai (UC-MSCs treatment)
Recruiting
- Mesenchymal Stem Cell
- COVID-19 Pneumonia
- UC-MSCs treatment
-
Shanghai, Shanghai, ChinaShanghai East Hospital, Shanghai Tongji University
Jan 17, 2023